You have 9 free searches left this month | for more free features.

cemiplimab

Showing 1 - 25 of 40

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Advanced NSCLC Trial (BNT116, Cemiplimab)

Not yet recruiting
  • Advanced Non-Small Cell Lung Cancer
  • (no location specified)
Sep 23, 2022

Secondary Angiosarcoma, Locally Advanced Sarcoma, Metastasis Trial in Nijmegen (Cemiplimab)

Recruiting
  • Secondary Angiosarcoma
  • +2 more
  • Cemiplimab
  • Nijmegen, Netherlands
    RadboudUMC
Jan 19, 2022

Hormone Receptor-positive Breast Cancer Trial in Tampa (Cemiplimab, Capecitabine)

Recruiting
  • Hormone Receptor-positive Breast Cancer
  • Tampa, Florida
    Moffitt Cancer Center
Jul 27, 2022

Cemiplimab to Historical Standard of Care in France

Recruiting
  • Cancer/Squamous Cell Carcinoma of Skin
  • Cemiplimab
  • France, France
    (unnamed)
Jun 6, 2022

Squamous Cell Carcinoma, Oropharynx Cancer, Head Neck Cancer Trial in Houston (SAR444245, Cemiplimab)

Not yet recruiting
  • Squamous Cell Carcinoma
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 7, 2022

Melanoma Trial in Orlando, Knoxville (Fianlimab, Cemiplimab, Pembrolizumab)

Recruiting
  • Melanoma
  • Orlando, Florida
  • +1 more
Jul 5, 2022

NSCLC Trial in Buderim, Adelaide (6-Thio-2'-Deoxyguanosine, Cemiplimab)

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Buderim, Queensland, Australia
  • +1 more
Jul 5, 2022

NSCLC Trial (Cemiplimab)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Cemiplimab
  • (no location specified)
Aug 8, 2022

HPV-Related Squamous Cell Carcinoma Trial in Baltimore (Cemiplimab)

Recruiting
  • HPV-Related Squamous Cell Carcinoma
  • Cemiplimab
  • Baltimore, Maryland
    Johns Hopkins University
Jan 10, 2022

Advanced Solid Tumor, Metastatic Solid Tumor Trial (89Zr?DFO?REGN5054, cemiplimab)

Not yet recruiting
  • Advanced Solid Tumor
  • Metastatic Solid Tumor
  • (no location specified)
Aug 5, 2022

Locally Advanced Head and Neck Squamous Cell Carcinoma Trial in New York (Cemiplimab, Cisplatin, Docetaxel)

Not yet recruiting
  • Locally Advanced Head and Neck Squamous Cell Carcinoma
  • Cemiplimab
  • +2 more
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Jun 9, 2022

NSCLC, Hepatocellular Carcinoma, Head and Neck Squamous Cell Carcinoma Trial in New York (cemiplimab, Platinum Doublet)

Recruiting
  • Non-small Cell Lung Cancer
  • +2 more
  • cemiplimab
  • Platinum Doublet
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Nov 24, 2021

Natural Killer/T-cell Lymphoma, Relapsed Natural Killer/T-cell Lymphoma, Refractory Natural Killer/T-cell Lymphoma Trial in

Recruiting
  • Natural Killer/T-cell Lymphoma
  • +2 more
  • Seoul, Kangnamgu, Korea, Republic of
    Samsung Medical Center
Sep 22, 2021

Cutaneous Squamous Cell Carcinoma, Basal Cell Carcinoma Trial in United States (Cemiplimab)

Recruiting
  • Cutaneous Squamous Cell Carcinoma
  • Cemiplimab
  • Redwood City, California
  • +8 more
Mar 28, 2022

Invasive Breast Cancer Trial in Milwaukee (Cemiplimab, Paclitaxel, Carboplatin (not mandatory))

Recruiting
  • Invasive Breast Cancer
  • Cemiplimab
  • +4 more
  • Milwaukee, Wisconsin
    Froedtert Hospital & Medical College of Wisconsin
Apr 1, 2022

Metastatic Castration-resistant Prostate Cancer Trial in United States (REGN4336, Cemiplimab, 18F-DCFPyL)

Recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • Palo Alto, California
  • +6 more
Aug 4, 2022

Squamous Cell Carcinoma of Head and Neck Trial in Spain, United States (REGN6569, Cemiplimab)

Recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • Los Angeles, California
  • +9 more
Jun 20, 2022

Cutaneous Squamous Cell Carcinoma Trial in Italy (Cemiplimab)

Recruiting
  • Cutaneous Squamous Cell Carcinoma
  • Cemiplimab
  • Bagno A Ripoli, Firenze, Italy
  • +6 more
Jul 27, 2022

Mycosis Fungoides Trial in Edmonton (Cemiplimab)

Not yet recruiting
  • Mycosis Fungoides
  • Cemiplimab
  • Edmonton, Alberta, Canada
    Cross Cancer Institute
Sep 12, 2022

Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Metastatic Head and Neck Squamous Cell Carcinoma,

Recruiting
  • Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
  • +24 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
May 18, 2022

Hodgkin Lymphoma Trial (Cemiplimab, Involved-site radiotherapy (IS-RT))

Withdrawn
  • Hodgkin Lymphoma
  • Cemiplimab
  • Involved-site radiotherapy (IS-RT)
  • (no location specified)
Jan 13, 2021

Metastatic Solid Tumor Trial in Groningen (89Zr-DFO-REGN3767, Cemiplimab)

Recruiting
  • Metastatic Solid Tumor
  • 89Zr-DFO-REGN3767
  • Cemiplimab
  • Groningen, Netherlands
    University Medical Center Groninen
Jan 24, 2022

Head Neck Cancer, Head Cancer, Head Cancer Neck Trial in United States (drug, procedure, radiation)

Recruiting
  • Head and Neck Cancer
  • +5 more
  • Basking Ridge, New Jersey
  • +5 more
Jul 27, 2022

Cutaneous Squamous Cell Carcinoma Trial in Australia, Germany, United States (Cemiplimab)

Active, not recruiting
  • Cutaneous Squamous Cell Carcinoma
  • Cemiplimab
  • Palo Alto, California
  • +21 more
Apr 5, 2022